{"schema_version":"secwatch.filing_event.v1","accession":"0001295947-22-000020","form_type":"8-K","ticker":"PBH","cik":"0001295947","company_name":"Prestige Consumer Healthcare Inc.","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.305504+00:00","generated_at":"2026-06-24T03:47:19.613659+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Prestige Q1 FY2023 revenue $277.1M, EPS $1.09, reaffirms full-year guidance","bullets":["Revenue $277.1M, +2.9% YoY; organic revenue (ex-Akorn, FX) declined 1.2%.","Diluted EPS $1.09 vs $1.14 prior year, but ahead of internal expectations.","Net cash from operations $58.2M; Non-GAAP free cash flow $57.2M.","Reaffirmed FY2023 guidance: revenue $1.12-1.13B, EPS $4.18-4.23, FCF >=$260M.","North American OTC flat at $242.5M; International OTC record $34.5M (+28.9%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001295947-22-000020","json":"https://secwatch.observer/filing/0001295947-22-000020.json","markdown":"https://secwatch.observer/filing/0001295947-22-000020.md","text":"https://secwatch.observer/filing/0001295947-22-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1295947/000129594722000020/0001295947-22-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1295947/000129594722000020/pbh-20220804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:47:19.613659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}